HR+ HER2- Early Breast Cancer

HR+ HER2- Early Breast Cancer

Managing Endocrine Therapy–Related Side Effects and Adherence in HR+/HER2- Early-Stage Breast Cancer

expert roundtables
By Virginia Kaklamani, MD, DSc; Ian Krop, MD, PhD; Melinda L. Telli, MD, FASCO

HR+ HER2- Early Breast Cancer

Expert Roundtables Podcast: Neoadjuvant Therapy for HR+/HER2- Early-Stage Breast Cancer

expert roundtables
By Virginia Kaklamani, MD, DSc; Ian Krop, MD, PhD; Melinda L. Telli, MD, FASCO

HR+ HER2- Early Breast Cancer

From Fatigue to Function: Unpacking Multidriver Symptom Clusters in Early-Stage Breast Cancer

patient care perspectives
By Melinda L. Telli, MD, FASCO

HR+ HER2- Early Breast Cancer

Multigene Assays and the Management of HR+/HER2- Early-Stage Breast Cancer

clinical topic updates
By Melinda L. Telli, MD, FASCO

HR+ HER2- Early Breast Cancer

The Multidisciplinary Care of Patients With Early-Stage Breast Cancer

patient care perspectives
By Ian Krop, MD, PhD